
Delgrel 150mg Tablet
Marketer
Gold Line
Salt Composition
Clopidogrel (150mg)
Overview Delgrel 150mg Tablet
CardioGuard 150mg tablets function as an antithrombotic agent, preventing the formation of dangerous blood clots within your circulatory system. This reduces your risk of stroke or myocardial infarction. Widely prescribed for cardiovascular protection, CardioGuard 150mg is indicated for individuals at elevated risk of heart disease, including those with peripheral arterial disease (circulatory issues from vascular narrowing), recent stroke or heart attack, arrhythmias, or post-stent placement. It's also employed adjunctively in treating heart attacks and unstable angina. This medication can be administered with or without food, consistently at the same time daily. Continued use is crucial, even during periods of wellness, as discontinuation increases the risk of cardiovascular events. The most prevalent adverse effect is bleeding, manifesting as bruising, epistaxis, hematuria, melena (dark stools), or heavier menstrual flow. Wound healing may be prolonged. While generally mild and self-limiting, persistent or concerning bleeding necessitates immediate medical consultation. This medication is contraindicated in individuals with active internal bleeding, such as a peptic ulcer or intracranial hemorrhage. Prior to commencement, disclose any history of bleeding disorders or recent major trauma or surgery to your physician. Temporary cessation may be necessary before scheduled surgical or dental procedures.
Primary Ingredients of Delgrel 150mg Tablet
No text provided to rephrase.
Uses of Delgrel 150mg Tablet
Reducing the risk of cardiovascular events
Major Benefits of Delgrel 150mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 150mg Delgrel tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
Common Side effects of Delgrel 150mg Tablet:
- Abdominal pain
- Bruise
- Diarrhea
- Hematoma
- Nosebleeds
- Gastrointestinal bleeding
- Dyspepsia
How to use Delgrel 150mg Tablet:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the 150mg Delgrel tablet whole; avoid chewing, crushing, or fracturing it. Consumption with or without food is acceptable, although consistent timing is recommended.
How Delgrel 150mg Tablet works:
Plavix 150mg tablets inhibit platelet aggregation, reducing the risk of dangerous blood clots and consequently lowering the likelihood of cardiovascular events such as stroke or myocardial infarction.
SAFETY ADVICE
AlcoholCAUTION
Exercise caution when drinking alcohol while taking Delgrel 150mg tablets. Seek medical advice.
PregnancyCONSULT YOUR DOCTOR
The use of Delgrel 150mg tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingSAFE IF PRESCRIBED
The use of Delgrel 150mg tablets while breastfeeding is likely safe. Available human data indicate minimal risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Delgrel 150mg tablets.
KidneySAFE IF PRESCRIBED
Renal impairment does not necessitate dosage modification for patients using 150mg Delgrel tablets; the medication is considered safe for this population.
LiverSAFE IF PRESCRIBED
Patients with hepatic impairment may safely take Delgrel 150mg tablets without requiring a dosage modification.
What if you forget to take Delgrel 150mg Tablet :
Should you forget to take your Delgrel 150mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Delgrel 150mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Amino acid alkyl esters |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavior Class | ADP receptor antagonists (P2Y12 inhibitors) |
